Success Metrics

Clinical Success Rate
75.0%

Based on 3 completed trials

Completion Rate
75%(3/4)
Active Trials
0(0%)
Results Posted
33%(1 trials)
Terminated
1(25%)

Phase Distribution

Ph phase_4
1
25%
Ph not_applicable
3
75%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution4 total trials
Phase 4Post-market surveillance
1(25.0%)
N/ANon-phased studies
3(75.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(3)
Terminated(1)

Detailed Status

Completed3
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
75.0%
Most Advanced
Phase 4

Trials by Phase

Phase 41 (25.0%)
N/A3 (75.0%)

Trials by Status

completed375%
terminated125%

Recent Activity

0 active trials
Showing 4 of 4
completednot_applicable

Comparison of Oral Care Solutions on Oral Microbial Colonization in Neurosurgical ICU Patients

NCT07365956
terminatednot_applicable

Development and Evaluation of a ChlorHexidine Gluconate bAthing pRotocol for Healthcare Settings in Low- and Middle-income Countries

NCT06590675
completedphase_4

Project PROTECT: Protecting Nursing Homes From Infections and Hospitalization

NCT03118232
completednot_applicable

Prevention of Nosocomial Bacteremia Among Zambian Neonates

NCT02386592

Clinical Trials (4)

Showing 4 of 4 trials
NCT07365956Not Applicable

Comparison of Oral Care Solutions on Oral Microbial Colonization in Neurosurgical ICU Patients

Completed
NCT06590675Not Applicable

Development and Evaluation of a ChlorHexidine Gluconate bAthing pRotocol for Healthcare Settings in Low- and Middle-income Countries

Terminated
NCT03118232Phase 4

Project PROTECT: Protecting Nursing Homes From Infections and Hospitalization

Completed
NCT02386592Not Applicable

Prevention of Nosocomial Bacteremia Among Zambian Neonates

Completed

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4